KLP Kapitalforvaltning’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
KLP Kapitalforvaltning's GLUE Position: Q3 2026 in Review
KLP Kapitalforvaltning held its Monte Rosa Therapeutics (GLUE) position steady in Q3 2026 at 10,900 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.
KLP Kapitalforvaltning first reported a position in GLUE in Q1 2026 and has held it in 3 quarters since. The position peaked at $264K in Q2 2026. 190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- KLP Kapitalforvaltning held 10,900 shares of Monte Rosa Therapeutics worth $130K as of Q3 2026.
- KLP Kapitalforvaltning left its Monte Rosa Therapeutics share count unchanged in Q3 2026.
- Monte Rosa Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2007 holding.
- KLP Kapitalforvaltning first reported a position in Monte Rosa Therapeutics in Q1 2026 and has held it in 3 quarters since.
- KLP Kapitalforvaltning's Monte Rosa Therapeutics position peaked at $264K in Q2 2026.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.